Le Lézard
Classified in: Business
Subject: PDT

Dollar Bank Increases Prime Rate


PITTSBURGH, Feb. 2, 2023 /PRNewswire/ -- Dollar Bank announced today that it is increasing its Prime Rate to 7.75% from 7.50% effective today. This increase is being made as a result of recent changes in market conditions.

About Dollar Bank
Dollar Bank has assets of more than $11 billion. Today, Dollar Bank operates more than 90 locations throughout Pennsylvania, Ohio, Virginia, and Maryland and has over 1,400 employees. For more than 166 years, Dollar Bank has grown to become the largest mutual bank in the United States, committed to providing the highest quality of banking services to individuals and businesses. Dedicated to aiding the communities it serves, Dollar Bank supports quality of life initiatives, financial literacy programs, and organizations devoted to helping individuals and families in need. Dollar Bank (www.dollar.bank) is headquartered in Pittsburgh, Pennsylvania.

SOURCE Dollar Bank


These press releases may also interest you

at 09:17
The following issues have been halted by CIRO Company: Medicus Pharma Ltd. TSX-Venture Symbol: MDCX  All Issues: Yes Reason: Pending News Halt Time (ET): 9:09 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 09:17
Risk3sixty, a leading cybersecurity technology and consulting firm, announced today that it has been named a Pacesetter Award winner by the Atlanta Business Chronicle for a sixth consecutive year. The Pacesetter Awards celebrate the 100...

at 09:15
via IBN...

at 09:15
The Seattle Kraken today announced new multi-year agreements with TEGNA and Prime Video to offer more options for fans to watch their games throughout the Pacific Northwest....

at 09:15
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...



News published on and distributed by: